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The prevalence of insulin resistance (IR) is rising worldwide due to increasing age, obesity, and physical inactivity. Insulin resistance is strongly associated with the metabolic syndrome (MetS) and is a required part of the MetS definition as originally described by Gerald Reaven in 1988 as Syndrome X. 1 Insulin resistance is also a defining component of MetS as specified by the World Health Organization 2 and the European Group for Study of Insulin Resistance. 3 However, in the 2005 National Cholesterol Education Program Adult Treatment Panel definition of MetS where 3 of 5 key components must be present, IR is not one of those components; however, glucose is one of those components and is a surrogate marker of IR. 4 Metabolic syndrome is associated with the development of coronary artery disease (CAD) and other atherosclerotic conditions. 4 With rapid economic growth and urbanization, the prevalence of MetS and diabetes mellitus (DM) in China is increasing, and the country is experiencing an epidemic of CAD. A large meta-analysis of 35 studies including 226 653 patients noted that the prevalence of MetS in mainland China was 24.5%. 5 The prevalence of DM among Chinese adults has been reported to be 12%. 6 It is therefore not surprising that CAD has become the leading cause of death in China, which in 2014 accounted for 44.60% and 42.51% of all deaths in rural and urban areas. 7 In a previous issue of Angiology, Wu et al investigated the correlation between IR and culprit plaque characteristics in patients with acute coronary syndrome (ACS). 8 Optimal coherence tomography (OCT) imaging was preferentially utilized for plaque imaging due to its high resolution (10-20 mm), allowing for more accurate identification of vulnerable plaque features, such as thin-cap fibroatheromas (TCFAs) and spotty calcifications. 8 Optimal coherence tomography detects calcium as a signal-poor darker area with well-delineated sharp borders. 9 Patients were semiquantitatively subclassified by Wu et al into 4 interquartile ranges according to the homeostasis model assessment of IR (HOMA-IR) values. 8 This model has been commonly used as a marker of IR because it is relatively simple to use and correlates quite well with the glucose clamp technique, recognized as the gold standard for the estimation of IR. 10 The main findings of the study of Wu et al were (i) patients in the higher HOMA-IR quartiles had more frequent vulnerable plaque characteristics such as TCFA and/or spotty calcifications as assessed by OCT and compared with those in the lower quartiles, (2) patients in the higher HOMA-IR quartiles had higher degrees of systemic inflammation (increased serum high sensitivity C-reactive protein levels) and local inflammation (greater macrophage and microtubule infiltration), and (3) higher HOMA-IR was an independent predictor of spotty calcification. 8 The findings of Wu et al confirm similar observations made by others, albeit in a uniquely Chinese population. The presence of calcification in coronary plaques is highly correlated with the overall degree of atherosclerosis and the rate of future cardiac events. 12 Superficial spotty calcification is likely an important morphological characteristic of a vulnerable plaque phenotype. A higher prevalence of TCFAs, lipid content, and microchannels have been observed in plaques with spotty calcification. 13 Mechanistically, vascular calcification has been considered an active participant in plaque development through its action on macrophages. Inflammatory cytokines released from macrophages promote osteogenic transformation of vascular cells that generate microcalcification.
14 In addition, a positive feedback loop exists, further stimulating macrophage activation and biomineralization, resulting in more calcification. 15 Thus, the finding of Wu et al that IR is independently predictive of the presence of spotty calcification can provide an explanation for the enhanced plaque vulnerability in this subgroup of patients. 8 The Wu et al study has some limitations. 8 It is a single-center study with modest statistical power. Certain patient characteristics are somewhat unusual when compared to those enrolled in typical contemporary ACS trials. For example, the average age was <50 years, and the average body mass index was only 25 kg/ m 2 ; a prior history of hypertension was noted in <50% of the cohort, while only about 35% had hyperlipidemia. 8 Hyperlipidemia (serum total cholesterol >240 mg/dL) was diagnosed in those receiving or not receiving lipid-lowering treatment. This 1 Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, USA specific cutoff level for hyperlipidemia may have resulted in the low incidence of hyperlipidemia, where hypertriglyceridemia and decreased high-density lipoproteins (HDL) are generally characteristic of increased IR. 16 For example, the triglycerides (TG)-HDL ratio has been shown to correlate with increased IR. 17, 18 Also, other correlations with increased IR have been made with (1) the lipid accumulation product, which is derived from waist circumference multiplied by TG concentration and (2) the TG/glucose index. 18 In addition, the possibility of selection bias in the registry cannot be excluded, since patients and plaques were specifically selected for OCT imaging by the operator. 8 Of note, East Asians and Africans appear to have a genetic background that increases susceptibility to DM. 19 How the results of Wu et al inform or guide our clinical decision-making is unclear. 8 The relative importance of individual plaque high-risk characteristics in predicting acute coronary events in the face of established risk factors such as IR and DM is not well defined. Atherosclerotic disease burden, however, is a consistent, powerful predictor of future ACS. Optimal management and treatment of traditional and wellestablished risk factors remain the standard of prevention, but the future could be the addition of now investigational lipid and inflammatory pathway targets that contribute further to plaque stabilization. 20 Following such advances, methods to identify and characterize the vulnerable plaque may become future standards of care.
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